Background: Polycystic ovarian syndrome (PCO) is a syndrome of ovarian dysfunction with polycystic ovary morphology and features of hyperandrogenism.
INTRODUCTION
Polycystic ovary syndrome (PCOS) is a complex metabolic/ endocrine disorder that affects 6% of women in reproductive age [1] . It is considered to be one of the important causes of female subfertility [2] . There is evidence that some genes may be responsible for the occurence of this syndrome, including those which codify the enzymes related to the metabolism of androgen in the ovary [3] .
Treatment of this syndrome includes: changing of life style, medical and surgical treatment [4] . Clomiphene was used to treat cases of oligomenorrhea and anovulation. Women undergoing treatment with clomiphen were found to have high rates of pregnancy [5] . Clomiphen use was associated with many side effects as ovarian enlargement; ovarian hyperstimulation syndrome; hot flushes; multiple pregnancies; gastrointestinal discomfort [6] .
Premature ovarian failure is a cause of female infertility. It has been found that ADSC significantly improved ovarian function after ovarian injury induced by chemotherapy. It was found that ADSC could increase oocyte and follicle number through changes in gene-expression and through production of cytokines [7] .
The main experimentally-induced PCO models in rat, that have been approved, include sex steroid-induced models, constant light exposure, hypothalamic lesions [8] . Moreover, Letrozole is an aromataze enzyme inhibitor that causes androgen excess and leads to development of polycystic ovary syndrome [9] .
AIM OF THE WORK
This work aimed to compare the effect of adiposederived stem cells to clomiphen on the treatment of experimentally-induced polycystic ovary in rats.
MATERIALS AND METHODS

(I) Adipose derived stem cells (ADSC):
PKH26 labeled ADSC were purchased from the Biochemistry Department, Faculty of Medicine, Cairo University. Cells were provided as first-passage culture cells suspended in phosphate buffered saline (PBS) solution. PBS was purshased from Gibco/ Invitrogen, Grand Island, New York, USA.
(II) Drugs: 1 . Letrozol (Trade name Femara): The drug was purchased from Novartis pharmaceutical company, Switzerland, in the form of tablets containing 2.5 mg of Letrozol. Tablets were crushed and dissolved in carboxmethlycellulose (CMC). CMC was purchased from Allergan pharmaceutical company, Ireland, in the form of eye drops (Trade name Refresh plus) containing 0.5% of carboxmethlycellulose sodium.
Clomiphen (Trade name Clomid):
The drug was purchased from Sanovi aventis pharmaceutical company, USA, in the form of tablets containing 50 mg of clomiphen citrate. Tablets were crushed and dissolved in normal saline.
(III) Animals:
The study was done at the Animal House of Kasr Al Ainy Faculty of Medicine, following the ethical guidelines for the use and care of Laboratory Animals, all the used procedures were approved with the local Ethics Committee. Fifty adult female rats, weighing 150-200g were used. All rats were selected in the estrous phase based on vaginal smears (Fig. 1A) . Estrous phase was identified by the presence of large cornified cells arranged in clumps. Rats were housed in hygienic stainless steel cages and kept in clean and well ventilated room. They were allowed free access to water and were fed standard chow diet. 
(IV) Experimental Design:
Rats were divided into two groups:
1. Control group (Group І): (n= 25rats) that received vehicle only (0.5 ml aqueous solution of carboxmethlycellulose (CMC) by intragastric intubation, once daily orally for 21 days.
PCO group (Group ІІ): (n= 25rats) that received
Letrozole at a concentration of 1 mg/kg (0.15mg -0.2mg) dissolved in 0.5 ml of CMC orally once daily given by intragastric intubation for 21 days [10] .
On the day subsequent to last letrozole dose administration, 5 rats from control group (Subgroup IA) and from the PCO group (Subgroup IIA) were sacrificed; their ovaries were excised. Specimens were fixed in buffered formalin solution and processed for paraffin sections. The sections were examined histologically to confirm the development of polycystic ovary in group ІІ.
The remaining 20 rats of the control group were subdivided into four subgroups: a. Subgroup ІB: (n=5rats) that continued without treatment for another fourteen days.
b. Subgroup ІC: (n=5rats) that received 0.5ml normal saline daily orally given by intragastric intubation for fourteen days.
c. Subgroup ІD: (n=5rats) that received single IV injection of 0.3 ml of PBS (pH 7.4) into the rat tail vein. The injection was repeated again the following day.
d. Subgroup ІE: (n=5rats) that received single IV injection of 0.3 ml of PBS (pH 7.4) ) into the rat tail vein for two successive days, then rats received 0.5ml normal saline daily orally for 12 days.
The remaining 20 rats of the PCO group were subdivided into four subgroups:
a. Subgroup ІІB: (Recovery group) (n=5rats) that continued without treatment for another fourteen days.
b. Subgroup ІІC: (n=5rats) that received clomiphene at concentration of 1 mg/kg (0.15mg -0.2mg) dissolved in 0.5ml normal saline orally given by intragastric intubation for fourteen days [10] .
c. Subgroup ІІD: (n=5rats) that received a single IV injection of 1 × 106 autologous ADSCs in a volume of 0.3 ml of PBS) into the rat tail vein. The injection was repeated again the following day at the same dose [7] .
d. Subgroup ІІE: (n=5rats) that received two injections of ADSCs on two successive days, followed by clomifen as previously described for 12 days.
After five weeks from the beginning of the experiment, all the rats were sacrificed; ovaries were excised.
Specimens were fixed in10% buffered formalin solution and processed for paraffin sections of 5~7 μm thickness, sections mounted on canada balsam coated slides in case of ordinary and special staining and poly-L-lysine coated and charged slides in case of immunostaining. The sections were subjected to the following histological stains :
• Hematoxylene and Eosin [11] .
• Periodic acid Schiff (PAS) reaction [11] .
• Immunohistochemical staining using and Ki 67 antibodies to test for proliferation of granulosa cells [12] .
Staining procedures for immunohistochemistry:
Paraffin sections were deparaffinized in xylene for 30 minutes and then rehydrated in descending grades of ethanol and then brought to distilled water for 5 minutes. Sections were incubated in hydrogen peroxide for 30 minutes and then rinsed in PBS (3 times, 2 minutes each). Primary antibody {Anti Ki-67 antibody: Ki67 (Clone SP6): A rabbit monoclonal antibody (Lab Vision Corporation laboratories, USA, RM-9106-R7)} was applied to the sections , 2 drops or 100μl for each section. Then slides were rinsed well in PBS (3 times, 2min. each), incubated for 20 minutes with 2 drops of biotinylated secondary antibody for each section then rinsed well with PBS. Each section was incubated with 2 drops (100 μl) enzyme conjugate "Streptavidin-Horseradish per oxidase" for 10 minutes at room temperature then washed in PBS. Substrate-chromogen (DAB) mixture 2 drops was applied to each section and incubated at room temperature for 5~10 min. then rinsed well with distilled water. Slides were counterstained with hematoxylin, dehydrated and mounted. All steps were performed in a humidity chamber to prevent drying of the tissues. Non-specific background elimination step was omitted. Ki-67 antibody: +ve cells showed brown nuclear deposits [12] .
Isolation, culture and labeling of ADSC
Adipose tissue was excised from the inguinal pad of fat in anaesthesized rat under complete aseptic condition. The adipose tissue was resected and placed into a sterile tube containing 15 ml of a PBS. Enzymatic digestion was performed using collagenase II (Serva Electrophoresis GmbH, Mannheim) in balanced Salt Solution for 60 minutes at 37°C. Digested tissue was filtered and centrifuged, and erythrocytes were removed by treatment with erythrocyte lysis buffer. The cells were transferred to tissue culture flasks with Dulbecco Modified Eagle Medium (DMEM, Gibco/ BRL, Grand Island, New York, USA) supplemented with 10% fetal bovine serum (Gibco/BRL) and, after an attachment period of 24 hours, non-adherent cells were removed by a PBS wash. Attached cells were cultured in DMEM media supplemented with 10% fetal bovine serum FBS, 1% penicillin-streptomycin (Gibco/ BRL), and 1.25 mg/L amphotericin B (Gibco/BRL), and expanded in vitro. At 80-90% confluence, cultures were washed twice with PBS and the cells were trypsinized with 0.25% trypsin in 1 mM EDTA (Gibco/BRL) for 5 min at 37°C.
After centrifugation, cells were resuspended with serumsupplemented medium and incubated in culture flask (Falcon) . The resulting cultures were referred to as firstpassage cultures and expanded in vitro until passage four [13] .
Subgroups IID and IIE received single IV injection of 1 × 106 PKH26 labelled ADSC in a volume of 0.3 ml of PBS (pH 7.4). The injection was repeated again the following day [7] . Localization of PKH26 labelled ADSC was visualized by the fluorescent microscope, in the ovaries of the injected rats (Fig. 1B) . 
Morphometric study:
Morphometric study done using Leica Qwin 500 LTD image analyser (Cambridge UK), measuring mean area percent of PAS, optical density of PAS reaction and immunopositivety of Ki 67 antibodies.
Statistical analysis:
Data were tabulated in the form of mean ± standard deviation. Comparisons between groups were done using unpaired t test when comparing 2 groups and analysis of variance (ANOVA) with multiple comparisons post hoc test when comparing more than 2 groups. The probability (P) value obtained from statistical tables was directly supplied to the computer using SPSS software version 16. Results were considered statistically significant when P value was < 0.05.
RESULTS :
I-Histological study:
1. Light microscopic examination of ovarian sections of the control group stained with Hematoxylene and Eosin showed the normal histological structure of the ovary ( Fig. 2A ). PCO group (subgroup IIA) showed large cystic ovarian follicles, ovarian follicles with thin granulosa layer and cell debris within the follicular cavity (Fig. 2B ). Subgroup IIB (Recovery group) appeared similar to those of PCO group with almost same findings (Fig. 2C ). Subgroup IIC (received clomiphen) showed improvement in the histological structure of the ovaries, where various stages of ovarian follicles were noticed, including corpora lutea (Fig. 2D ). Subgroup IID (received ADSC) showed few ovarian cysts and ovarian follicles in different stages of development ( Fig. 2E ) Subgroup IIE (received ADSC+ clomiphen) showed histological structure similar to that seen in the control group (Fig. 2F ).
2. PAS stained sections: Examination of ovarian sections of the control group showed strong positive PAS reaction in the intercellular spaces between granulosa cells, within the theca layer and in the granulsa basement membranes and in zona pellucida (Fig. 3A) . PCO group (subgroup IIA) showed decreased PAS reaction in the intercellular spaces within the follicular wall and strong one in the theca layer (Fig. 3B ). Subgroup IIB (recovery group) showed almost same results as subgroup IIA (Fig. 3C ). Subgroup IIC (received clomiphen) strong positive PAS reaction in the intercellular spaces between granulosa cells, within the theca layer and in the granulsa basement membranes and in zona pellucida (Fig. 3D ). Subgroup IID (received ADSC) showed strong positive PAS reaction in the intercellular spaces paces between granulosa cells, within the theca layer and in the granulsa basement membranes and in zona pellucida (Fig. 3E ). Subgroup IIE (received ADSC + clomiphen ) strong positive PAS reaction in the intercellular spaces between granulosa cells, within the theca layer and in the granulsa basement membranes and in zona pellucida. (Fig. 3F ).
Morphometric results (Tables 1-4):
Three weeks after starting the experiment, the mean area % of PAS positive reaction showed significant decrease in the granulosa of PCO group compared to the control, however the mean area % in the theca layer of the PCO group showed non-significant increase compared to the control. Five weeks after the experiment, the mean area % showed a significant decrease in the granulosa and a non-significant increase in the theca of the recovery group compared to the control subgroups.The mean area % in the granulosa of subgroup IIC (received clomiphen), subgroup IID (received ADSCs) and subgroup IIE (received ADSCs + clomiphen) were significantly higher than that in the recovery group, however, the comparison was nonsignificant in the theca layer. On comparing subgroup ІІC and subgroup ІІD there was no significant difference in mean area % neither in the granulosa nor in the theca. On comparing subgroup ІІE either with subgroupІІC or with subgroup ІІD there was also no significant difference neither in the granulosa nor in the theca. Moreover, the optical density of PAS positive reaction showed similar statistical results except that on comparing subgroup ІІE with subgroup ІІD, the optical density was significantly higher in granulosa of subgroup ІІE, while no significant difference was found in the theca.
2-Immuohistochemical study:
Ovarian sections of the control group (Group I) and its subgroups immunostained for Ki 67, showed strong positive immunoreactivity in nuclei of follicular cells and less one in the theca layer (Fig. 4A) . PCO group (Group IIA) showed weak positive immunostaining of the thinned-out granulosa layer (Fig. 4B) . Subgroup IIB showed weak positive immunostaining of the thinned-out granulosa layer (Fig. 4C ).
Subgroup IIC (received clomiphen) showed strong positive immunoreaction of granulosa cells and few one in theca layer (Fig. 4D ). Subgroup IID (received ADSC) immunostained for Ki 67 showed strong positive Ki 67 immunoreaction of granulosa cells and few one in theca layer (Fig. 4E ). Subgroup IIE (received ADSC+clomiphen) showed strong positive Ki 67 immunoreaction of granulosa cells and few one in theca layer (Fig. 4F) .
Morphometric results (Tables 5&6):
The mean area % of Ki 67 immunoreactivity, 3 weeks from the beginning of the experiment, showed a significant decrease in the granulosa of PCO group compared to the control. After 5 weeks of the experiment, this mean area % in the granulosa of the recovery group showed significant decrease when compared to the control subgroups. The mean area % in the granulosa of subgroups IIC , IID and IIE were significantly higher than that in the recovery group. On comparing subgroup ІІC and subgroup ІІD, the mean area % was significantly higher in the granulosa of subgroup ІІC. The mean area % was significantly higher in the granulosa of subgroup ІІE as compared to either subgroup ІІC or IID. , secondary follicles at different stages of growth (SF), corpus luteum (CL).
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DISCUSSION
Polycystic ovary syndrome (PCOS) has been considered as one of the most controversial syndromes in gynecology and endocrinology. Numerous discussions and consensuses for diagnosis had been created due to the heterogeneity of this syndrome [1] .
Despite clomiphen was considered the first line of treatment of infertility associated with PCOS [4] , it was associated with numerous side effects [6] . On the other hand, ADSC was reported to improve significantly the ovarian functions after chemotherapy-induced ovarian injury. It was suggested that it could increase oocytes and follicles number [7] .
Accordingly, the present study was designed to compare the effect of adipose-derived stem cells versus clomiphen on the treatment of experimentally-induced polycystic ovary in rats.
Many rat models had been used to investigate this syndrome [14] . In the present study letrozole was used to produce an animal model of PCOS. Letrozole is a non-steroidal aromatase inhibitor, it produces complete inhibition of aromatase enyme thus blocking the conversion of androgen to estrogen leading to suppression of estrogen and increase of androgen. Many authors suggested that letrozole administration in female adult rats could induce PCO features that resemble the disease features in human beings [10 ] .
In order to begin the experiment in the same phase for all the groups, all rats were selected in their estrous phase of estrous cycle. This selection was achieved using microscopic examination of vaginal smears. Under microscope, estrous phase was characterized by predominance of large cornified cells arranged in clumps, this agrees with what was suggested by some reporters, who identified this phase during cytological examination of vaginal cells by showing almost large cornified cells arranged in clumps [15] . Microscopic examination of ovarian specimens from the control group, three weeks from the beginning of the experiment, showed normal histological structure of the ovary with follicles in different stages of development, in addition to corpora lutea. On the other hand, specimens from the PCO group showed dilated ovarian cysts, dilated ovarian follicles that exhibited thin granulosa layer and debris within the follicular cavity, in addition to multiple atretic follicles. Similar findings were detected by some authors who also observed multiple cysts in letrozole-induced PCO rats.. They also reported that letrozole induced-PCOS rats showed significant number of atretic follicles randomly spread between other follicles, disruption of the granulosa layer, with cell debris in the follicular cavity [15] .
Five weeks from the beginning of the experiment, specimens from control subgroups appeared similar to those of control subgroups after 3 weeks. On the other hand, the specimens from the recovery group appeared nearly similar to those of the PCO group. Meanwhile, the other subgroups receiving clomiphen, ADSC and combined clomiphen with ADSC, showed improvement in their histological structure. Various stages of ovarian follicles were noticed, including corpora lutea but few cysts were still observed. Similar results were reported by some authors, who reported marked recovery in the specimens from PCO rats treated with clomiphen [10] . Similarly, other authors reported improvement in the histological structure of the ovarian tissue, in the female rats suffering from ovarian failure induced by chemotherapy, after injection of ADSC [7] . In accordance with the current work, they detected numerous follicles at all stages of development in the ovarian specimens of the ADSC-treated female mice. Concomitant observations were also mentioned by some reporters where the total number of follicles and corpora lutea was increased following ADSC therapy of ovarian failure [17] .
An important character of stem cells is their ability to selectively home to sites of tissue inflammation or damage [18] . In the present study, intravenously injected ADSC have migrated to the damaged ovary. This was confirmed by localization of PKH26 labelled ADSC visualized by the fluorescent microscope in the ovaries of the injected rats.Stem Cells have the ability to recognize the damaged site, then it can home and integrate into this site. Homing of ADSC to sites of injury might be caused by certain substances released from sites of tissue damage or inflammation. Increased chemokine concentration at the inflamed or damaged sites likely directs ADSC migration to these sites [19] . ADSC express receptors for several chemokines such as Tumor Necrosis Factoralpha, Fibroblast growth factor-2 and Endothelial growth factor [20] .
In the present study, follicles at different stages of development were detected in the ovaries of the ADSCtreated group. The mechanism of recovery of ovarian function and folliculogenesis following after ADSC therapy has not been fully explained, but many studies suggested some mechanisms such as increasing number of follicles and reducing apoptosis of granulosa cells, and subsequent recovery of ovarian sex hormone function [7] .
It was suggested that ADSC migrating to damaged or inflammed tissues may act by two mechanisms: differentiation into cells specific to the tissue and/or paracrine effects [21] . Moreover, analysis of the factors released from ADSC revealed that cultured ADSC, at relatively early passages, secrete hematopoietic, angiogenic and anti-apoptotic factors in addition to cytokines and growth factors [22] . After 3 weeks of the experiment, ovarian specimens from the control group stained with PAS showed strong positive PAS staining in the intercellular spaces between granulosa cells, within the theca layer, in the granulosa basement membranes and in zona pellucida. On the other hand, examination of ovarian sections of PCO group (Group II) showed significant decrease in the mean area % of positive PAS reaction in the granulosa layer compared to the control ovarian sections. However, the mean area % in the theca of this group was non-significantly increased as compared to the control. Also, comparable results were detected when measuring the optical density on the specimens of these two groups. These results appeared close to those of some reporters who observed that the theca layer showed significantly higher PAS staining in PCO ovaries, while, in the granulosa layer, the PAS staining was significantly lower in PCO ovaries. They also observed that, in the control, the granulosa layer was more significantly stained than that in PCO ovaries, while, in the theca layer the intensity of PAS staining was significantly higher in cystic ovaries than that in the control [23] .
In the current study, the mean area % of PAS positive reaction of the granulosa showed significant decrease in the recovery group (subgroup IIB) compared to the control, while, that in the theca showed a non-significant increase. Similar results were detected on assessment of the optical density in these subgroups. Meanwhile, the mean area % of PAS reactivity in the granulosa of subgroup IIC (received clomiphen), subgroup IID (received ADSCs) and subgroup IIE (received ADSCs + clomiphen) were significantly higher than that in the recovery group. However, the comparison was non-significant in the mean area% in all three subgroups in the theca layer.These results were comparable to what was found on measuring the optical density between these subgroups. On the other hand, on comparing subgroups ІІC, ІІD and ІІE, there was no significant difference in mean area % of PAS reaction neither in the granulosa nor in the theca and comparable results were found on measuring the optical density.
It is worth mentioning that folliculogenesis is characterized by granulosa cells proliferation, differentiation of the theca cells from the ovarian stroma, and basement membrane deposition thus separating the theca layer from avascular granulosa cells. Unlike the granulosa cells, the theca layer is well vascularized and contains circumferential collagen bundles. Changes in the extracellular matrix (ECM) can influence gene expression as well as cell migration, proliferation, apoptosis and differentiation.It was suggested that most of the ECM components in the ovarian follicles are synthesized by the granulosa cells. It was also suggested that granulosa cells secrete a mucopolysaccharide-rich fluid that coalesces forming the antrum of the secondary follicle [24] .
In the present study, the strong PAS reaction seen in the theca layer, could be attributed to the increased amount of carbohydrates and GAGs associated with the increased amount of collagen present. This assumption can be based on some studies which reported increased collagen deposition in the ovaries of rats with PCOS [25] .
The above suggestions point to the important role of carbohydrates and GAGs secreted by granulosa cells in the differentiation and development of ovarian follicles. This might explain the significant decrease of carbohydrates and GAGs found in the granulosa of cystic ovaries in comparison to the control and to the treated subgroups, in the present study. In contrast, the strong staining seen in the theca of cystic ovaries could be attributed to the increased amount of collagen deposition [25] .
After 3 weeks of the experiment, the mean area % of Ki 67 immunoreactivity, showed significant decrease in the granulosa of the PCO group compared to the control ovarian sections. This coincided well with the results of a study that evaluated proliferation in the ovary of rats with PCOS. It reported that proliferation was significantly higher in the granulosa cells of the control specimen [12] .
After 5 weeks of the experiment, the mean area % of Ki 67 immunoreactivity of the recovery group (subgroup IIB) failed to return to the normal levels as it showed significant decrease in the immunoreactivity of thinned out granulosa when compared to the control subgroups. Meanwhile, the mean area % of Ki 67 immunoreactivity in the granulosa of the treated subgroups IIC, IID and IIE were significantly higher than that in the recovery group. This substantiates more the known effective role of clomiphen being the standard first choice for treating PCOS, in addition to presenting a hopeful effective role of ADSC as an alternative or complementary therapy. This effect of ADSC could be explained by the fact that these cells probably migrated towards the ovary, to be a source of stem cells capable of regenerating the population of primordial follicles and greatly preventing their apoptosis.
On comparing subgroup ІІE with subgroup ІІC, the mean area % of Ki67 immunoreactivity was significantly higher in the granulosa of subgroup ІІE. This again supports the possible effective role of combining ADSC and clomiphen, which may be beneficial in the future therapy of PCOS.
Moreover, in the present study, the significant increase in Ki67 immuno-expression, detected in the granulosa of the groups treated by clomiphen and/or stem cells, reflects the increased number of granulosa cells after treatment.
This assumption could be supported by some reporters, who studied the effect of clomiphen on rat ovarian histology. They found that clomiphen could increase the number of granulosa cells and they raised the possibility that clomiphen may increase the risk of granulosa cell tumours especially if used in high doses [26] . In another study done, the ability of the human embryonic stem cells to differentiate into functioning granulosa cells was tested. The authors found that stem cells could differentiate to granulosa cells that were able to transfer testosterone into estrogen indicating that they are biologically active [27] .
In the present study, leaving the PCO affected rats for natural recovery was non-sufficient to restore the histological findings compared to the treated groups and control. Similarly, in another study a group of letrozole-induced PCOS rats was left for natural recovery, the authors found that the recovery period was non-sufficient to restore the histological findings as compared to Clomiphene citrate treatment, as many cysts and atretic follicles were still found [10] .
Taken all together, the results of the current study might draw attention to an effective role for ADSC in treatment of PCOS as its effect was comparable to that of clomiphen, which is currently the best drug recommended for treating infertility induced by PCOS, but in some cases it is not recommended or causes various side-effects. It is to be noted that ADSC and clompihen act via different pathways of modes of action, where clomiphene acts as a selective estrogen receptor modulator, inducing a change in gonadotropin releasing hormone (GnRH) pulse frequency leading to increased release of follicle stimulating hormone (FSH) from the pituitary gland [28] . On the other hand, ADSC could repair and regenerate the damaged ovarian tissue [29] . It could be proposed that both drugs act together in synergism, where the added effect of their combination was higher than the individual result of each of them separately.This synergistic drug combination allows lower doses of each constituent drug and consequently less adverse effects [30] .
CONCLUSION:
In the present study, both clomiphen and ADSC could improve ovarian structure in this rat model of PCOS. Clomiphen effect was found to be comparable to that of ADSC, while combining ADSC + Clomiphen gave the best results. 
